Name | BMS-790052 |
Synonyms | CS-32 BMS-7052 BMS-790052 Daclatasvir Daclatasvir (BMS-790052) DACLATASVIR (BMS-790052) dimethyl (2S,2'S)-1,1'-((2S,2'S)-2,2'-(4,4'-(biphenyl-4,4'-diyl)bis(1H-imidazole-4,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl)dicarbamate Carbamic acid, N,N'-[[1,1'-biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-, dimethyl ester Methyl [(2S)-1-{(2S)-2-[5-(4'-{2-[(2S)-1-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}-2-pyrrolidinyl]-1H-imidazol-5-yl}-4-biphenylyl)-1H-imidazol-2-yl]-1-pyrrolidinyl}-3-methyl-1-oxo-2-butanyl]c arbamate |
CAS | 1009119-64-5 1214735-16-6 |
InChI | InChI=1S/C40H50N8O6/c1-23(2)33(45-39(51)53-5)37(49)47-19-7-9-31(47)35-41-21-29(43-35)27-15-11-25(12-16-27)26-13-17-28(18-14-26)30-22-42-36(44-30)32-10-8-20-48(32)38(50)34(24(3)4)46-40(52)54-6/h11-18,21-24,31-34H,7-10,19-20H2,1-6H3,(H,41,43)(H,42,44)(H,45,51)(H,46,52)/t31-,32-,33-,34-/m0/s1 |
Molecular Formula | C40H50N8O6 |
Storage Condition | -20℃ |
Use | Daclatasvir (BMS-790052) is a highly selective HCV NS5A inhibitor with EC50 of 9-50 pM. In cell culture, it acts on infectious viruses of various HCV replication genotypes and JFH-1 genotype 2a. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 1.353 ml | 6.767 ml | 13.534 ml |
5 mM | 0.271 ml | 1.353 ml | 2.707 ml |
10 mM | 0.135 ml | 0.677 ml | 1.353 ml |
5 mM | 0.027 ml | 0.135 ml | 0.271 ml |